Prometheus reiterates broad patent eligibility standard
Bilski has done little to change the Federal Circuit’s approach to assessing the patent eligibility of diagnostic method claims, according to an opinion issued last week
The Federal Circuit originally ruled in Prometheus v Mayo (2009) that the claims at issue - which cover methods of determining the proper dosage of thiopurine drugs in patients - satisfied both prongs of the court's machine-or-transformation test, as they...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.